By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
MRVI insiders were on both sides of the trade this year. Buys came to roughly $1.9 million (two buyers), sales to $254,000 (one seller).
Brust Bernd (CEO) made the biggest buy, worth around $703,000. Notably, at least one C-suite executive was among the buyers.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters. 178 investment managers listed MRVI in their latest 13F filings (Q2 2026); more funds bought than sold.
Are insiders buying or selling MRVI stock?
In the last 12 months Maravai Lifesciences Holdings, Inc. insiders made open-market purchases worth about $1.9 million and sales worth about $254,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in MRVI?
The most recent open-market insider trade in MRVI was filed on 2026-06-10.
How many institutions own MRVI?
178 investment managers reported holding MRVI in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded MRVI?
No congressional trades in MRVI were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).